A drug that brings the benefits gained from medical cannabis without the “high” or other side effects may help to unlock a new treatment for Parkinson’s disease. The drug, known as HU-308, reduces devastating involuntary movements called dyskinesias, a side effect from years of treatment for Parkinson’s disease. “Our study suggests that a derivative of… Read more

Drugs that quell inflammation in the brain could slow or even reverse the cognitive decline that comes with age. Senile mice given one such drug had fewer signs of brain inflammation and were better able to learn new tasks, becoming almost as adept as mice half their age. “We tend to think about the aged… Read more

Inflammation drives the progression of neurodegenerative brain diseases and plays a major role in the accumulation of tau proteins within neurons, research indicates[1]. The findings, from an international research team led by the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn, are based on the analyses of human brain tissue and further… Read more

Inflammation appears to have a particular negative impact on the brain’s readiness to reach and maintain an alert state, according to scientists at the University of Birmingham in collaboration with the University of Amsterdam. “Scientists have long suspected a link between inflammation and cognition, but it is very difficult to be clear about the cause… Read more

Anti-inflammatory agents, such as aspirin/paracetamol, statins, and antibiotics, can safely and effectively curb the symptoms of major depression, finds a newly published meta-analysis of the available evidence. And the effects are even stronger when these agents are added on to standard antidepressant treatment, the results show. Around a third of people who are clinically depressed… Read more